Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Lee’s Pharma to Distribute PAH Drug in China

publication date: Jul 22, 2010
Lee's Pharmaceutical, which is headquartered in Hong Kong, will be the exclusive China distributor for Remodulin, a United Therapeutics product. Remodulin is a prostacyclin analogue for the treatment of pulmonary arterial hypertension. Lee's Pharma will be responsible for obtaining approval of the drug in China, which will include conducting bridging studies. More details....

Stock Symbols: (GEM: 8221) (NSDQ: UTHR)

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event

Device China 2018
September 8-9, 2018